Michael Yang, MD
Visiting Associate Professor, Pathology

Photo
Department: Pathology

Publications

  • He T, Wildey G, McColl K, Savadelis A, Spainhower K, McColl C, Kresak A, Tan AC, Yang M, Abbas A, Dowlati A. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer. Mol Oncol. 2021 Jan;15(1):195-209. PubMed PMID: 33084222
  • Alilou M, Prasanna P, Bera K, Gupta A, Rajiah P, Yang M, Jacono F, Velcheti V, Gilkeson R, Linden P, Madabhushi A. A Novel Nodule Edge Sharpness Radiomic Biomarker Improves Performance of Lung-RADS for Distinguishing Adenocarcinomas from Granulomas on Non-Contrast CT Scans. Cancers (Basel). 2021 Jun 3;13(11). PubMed PMID: 34205005
  • Wang X, Bera K, Barrera C, Zhou Y, Lu C, Vaidya P, Fu P, Yang M, Schmid RA, Berezowska S, Choi H, Velcheti V, Madabhushi A. A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer. EBioMedicine. 2021 Jul;69:103481. PubMed PMID: 34265509
  • He T, Wildey G, McColl K, Savadelis A, Spainhower K, McColl C, Kresak A, Tan AC, Yang M, Abbas A, Dowlati A. Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer. Mol Oncol. 2020 Oct 20. [Epub ahead of print] PubMed PMID: 33084222
  • Lu C, Bera K, Wang X, Prasanna P, Xu J, Janowczyk A, Beig N, Yang M, Fu P, Lewis J, Choi H, Schmid RA, Berezowska S, Schalper K, Rimm D, Velcheti V, Madabhushi A. A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study. Lancet Digit Health. 2020 Nov;2(11):e594-e606. PubMed PMID: 33163952

Practice Locations

UCH - Anschutz Inpatient Pavilion
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

Specialty Information

Specialties
  • Pathology, Board Certification

General Information

Department: Pathology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;